Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1637 1656 1681 1699
This examiner grants 65% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17254886 | CRISPR DOUBLE NICKASE BASED AMPLIFICATION COMPOSITIONS, SYSTEMS, AND METHODS | Non-Final OA | PRESIDENT AND FELLOWS OF HARVARD COLLEGE |
| 18016776 | COMPOSITIONS AND METHODS OF ISOTHERMAL NUCLEIC ACID AMPLIFICATION AND DETECTION | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 18813886 | COMPOSITIONS AND METHODS FOR DETECTING BINDING INTERACTIONS UNDER EQUILIBRIUM OR NON-EQUILIBRIUM CONDITIONS | Final Rejection | Nautilus Subsidiary, Inc. |
| 17933753 | METHODS AND COMPOSITIONS FOR PROCESSING BOTANICAL MATERIALS | Non-Final OA | The Chinese University of Hong Kong |
| 18324552 | SINGLE-STRANDED NUCLEIC ACID APTAMERS SPECIFICALLY BINDING TO CRONOBACTER AND KIT FOR DETECTING CRONOBACTER USING THE SAME | Final Rejection | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY |
| 18115335 | ISOTHERMAL NUCLEIC ACID DETECTION ASSAYS AND USES THEREOF | Non-Final OA | TRUSTEES OF BOSTON UNIVERSITY |
| 18301565 | METHODS AND SYSTEMS FOR PROCESSING POLYNUCLEOTIDES | Final Rejection | 10x Genomics, Inc. |
| 18317484 | COMPOSITIONS AND METHODS FOR IMMUNE REPERTOIRE MONITORING | Non-Final OA | Life Technologies Corporation |
| 18137956 | Methods and Kits to Detect Viral Particle Heterogeneity | Final Rejection | LIFE TECHNOLOGIES CORPORATION |
| 17928702 | METHODS OF DETERMINING BACTERIA AND MANUFACTURING A FIBROUS WEB AND TOOLS AND USES RELATED THERETO | Non-Final OA | KEMIRA OYJ |
| 18122657 | MODIFIED NUCLEOSIDE PHOSPHATES WITH HIGH THERMAL STABILITY | Non-Final OA | Roche Molecular Systems, Inc. |
| 17999023 | METHODS FOR PAIRED-END SEQUENCING LIBRARY PREPARATION | Non-Final OA | Element Biosciences, Inc. |
| 16757297 | METHODS AND COMPOSITIONS FOR THE PURIFICATION OF UNBIASED RNA | Final Rejection | ZYMO RESEARCH CORPORATION |
| 18395034 | VIABLE CELL DETECTION AND PROTOCOL IMPLEMENTING THE SAME | Non-Final OA | Trace-Ability, Inc. |
| 18485867 | SINGLE END DUPLEX DNA SEQUENCING | Non-Final OA | QIAGEN SCIENCES, LLC |
| 18132703 | METHODS AND SYSTEMS FOR NUCLEIC ACID SEQUENCING | Non-Final OA | ULTIMA GENOMICS, INC. |
| 18349394 | COMPOSITION AND THE USE OF CELL LYSIS REAGENTS | Non-Final OA | Vilnius University |
| 18236022 | BIOMARKERS OF RISK FOR INFECTION | Final Rejection | University of Chicago |
| 17639399 | SKIN MICROBIOME MONITORING FOR IMPROVING SYSTEMIC HEALTH | Final Rejection | MY-OR DIAGNOSTICS LTD. |
| 18204703 | DETECTION OF TARGET NUCLEIC ACIDS | Non-Final OA | Saga Diagnostics AB |
| 18060421 | MODIFIED PRIMERS FOR LOOP-MEDIATED ISOTHERMAL AMPLIFICATION AND USE THEREOF | Final Rejection | 1DROP INC. |
| 17964798 | NUCLEIC ACID CONSTRUCTS AND METHODS OF USE | Non-Final OA | Prognosys Biosciences, Inc. |
| 17774249 | BIVALENT REVERSE PRIMER | Non-Final OA | MIRNAX BIOSENS, S.L. |
| 17614892 | Detection of Antibiotic Resistance Genes | Non-Final OA | STRECK, INC. |
| 17293085 | MULTIMER FOR SEQUENCING AND METHODS FOR PREPARING AND ANALYZING THE SAME | Non-Final OA | FORESEE GENOMICS, LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy